» Articles » PMID: 28903501

Sex-Differential Responses of Tumor Promotion-Associated Genes and Dysregulation of Novel Long Noncoding RNAs in Constitutive Androstane Receptor-Activated Mouse Liver

Overview
Journal Toxicol Sci
Specialty Toxicology
Date 2017 Sep 15
PMID 28903501
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Xenobiotic agonists of constitutive androstane receptor (CAR) induce many hepatic drug metabolizing enzymes, but following prolonged exposure, promote hepatocellular carcinoma, most notably in male mouse liver. Here, we used nuclear RNA-seq to characterize global changes in the mouse liver transcriptome following exposure to the CAR-specific agonist ligand 1,4-bis-[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP), including changes in novel long noncoding RNAs that may contribute to xenobiotic-induced pathophysiology. Protein-coding genes dysregulated by 3 h TCPOBOP exposure were strongly enriched in KEGG pathways of xenobiotic and drug metabolism, with stronger and more extensive gene responses observed in female than male liver. After 27 h TCPOBOP exposure, the number of responsive genes increased >8-fold in males, where the top enriched pathways and their upstream regulators expanded to include factors implicated in cell cycle dysregulation and hepatocellular carcinoma progression (cyclin-D1, oncogenes E2f, Yap, Rb, Myc, and proto-oncogenes β-catenin, FoxM1, FoxO1, all predicted to be activated by TCPOBOP in male but not female liver; and tumor suppressors p21 and p53, both predicted to be inhibited). Upstream regulators uniquely associated with 3 h TCPOBOP-exposed females include TNF/NFkB pathway members, which negatively regulate CAR-dependent proliferative responses and may contribute to the relative resistance of female liver to TCPOBOP-induced tumor promotion. These responses may be modified by the many long noncoding liver RNAs we show are dysregulated by TCPOBOP or pregnane-X-receptor agonist exposure, including lncRNAs proximal to CAR target genes Cyp2b10, Por, and Alas1. These data provide a comprehensive view of the CAR-regulated transcriptome and give insight into the mechanism of sex-biased susceptibility to CAR-dependent mouse liver tumorigenesis.

Citing Articles

Transcriptomic landscape of Hras12V oncogene-induced hepatocarcinogenesis with gender disparity.

Di H, Rong Z, Mao N, Li H, Chen J, Liu R BMC Cancer. 2025; 25(1):94.

PMID: 39819515 PMC: 11737189. DOI: 10.1186/s12885-025-13476-7.


HDI-STARR-seq: Condition-specific enhancer discovery in mouse liver in vivo.

Chang T, Waxman D BMC Genomics. 2024; 25(1):1240.

PMID: 39716078 PMC: 11668083. DOI: 10.1186/s12864-024-11162-9.


HDI-STARR-seq: Condition-specific enhancer discovery in mouse liver in vivo.

Chang T, Waxman D bioRxiv. 2024; .

PMID: 38915578 PMC: 11195054. DOI: 10.1101/2024.06.10.598329.


Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression.

Sonkar R, Ma H, Waxman D Toxicol Sci. 2024; 200(2):324-345.

PMID: 38710495 PMC: 11285164. DOI: 10.1093/toxsci/kfae057.


Pharmacological activation of constitutive androstane receptor induces female-specific modulation of hepatic metabolism.

Huillet M, Lasserre F, Gratacap M, Engelmann B, Bruse J, Polizzi A JHEP Rep. 2023; 6(1):100930.

PMID: 38149074 PMC: 10749885. DOI: 10.1016/j.jhepr.2023.100930.


References
1.
Jirawatnotai S, Hu Y, Michowski W, Elias J, Becks L, Bienvenu F . A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature. 2011; 474(7350):230-4. PMC: 3134411. DOI: 10.1038/nature10155. View

2.
Klingenberg M, Matsuda A, Diederichs S, Patel T . Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets. J Hepatol. 2017; 67(3):603-618. DOI: 10.1016/j.jhep.2017.04.009. View

3.
Ledda-Columbano G, Pibiri M, Concas D, Cossu C, Tripodi M, Columbano A . Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli. Hepatology. 2002; 36(5):1098-105. DOI: 10.1053/jhep.2002.36159. View

4.
Kazantseva Y, Yarushkin A, Pustylnyak V . CAR-mediated repression of Foxo1 transcriptional activity regulates the cell cycle inhibitor p21 in mouse livers. Toxicology. 2014; 321:73-9. DOI: 10.1016/j.tox.2014.04.003. View

5.
Braeuning A, Henderson C, Wolf C, Schwarz M . Model Systems for Understanding Mechanisms of Nongenotoxic Carcinogenesis: Response. Toxicol Sci. 2015; 147(2):299-300. View